BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23032070)

  • 21. Bone mineral density in adult patients treated with various antiepileptic drugs.
    Beniczky SA; Viken J; Jensen LT; Andersen NB
    Seizure; 2012 Jul; 21(6):471-2. PubMed ID: 22541979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homocysteine and bone loss in epilepsy.
    Elliott JO; Jacobson MP; Haneef Z
    Seizure; 2007 Jan; 16(1):22-34. PubMed ID: 17110134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Saliva and serum levetiracetam concentrations in patients with epilepsy.
    Mecarelli O; Li Voti P; Pro S; Romolo FS; Rotolo M; Pulitano P; Accornero N; Vanacore N
    Ther Drug Monit; 2007 Jun; 29(3):313-8. PubMed ID: 17529888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between BsmI polymorphism and bone mineral density in young patients with epilepsy who are taking phenytoin.
    Phabphal K; Geater A; Limapichart K; Sathirapanya P; Setthawatcharawanich S; Witeerungrot N; Thammakumpee N; Leelawattana R
    Epilepsia; 2013 Feb; 54(2):249-55. PubMed ID: 23281616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of valproate, lamotrigine, and levetiracetam monotherapy on bone health in newly diagnosed adult patients with epilepsy.
    Guo Y; Lin Z; Huang Y; Yu L
    Epilepsy Behav; 2020 Dec; 113():107489. PubMed ID: 33220583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
    Otoul C; De Smedt H; Stockis A
    Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levetiracetam monotherapy for late poststroke seizures in the elderly.
    Kutlu G; Gomceli YB; Unal Y; Inan LE
    Epilepsy Behav; 2008 Oct; 13(3):542-4. PubMed ID: 18539085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
    van Vliet EA; Edelbroek PM; Gorter JA
    Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
    Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
    Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced bone mass and increased bone turnover in postmenopausal women with epilepsy using antiepileptic drug monotherapy.
    Lyngstad-Brechan MA; Taubøll E; Nakken KO; Gjerstad L; Godang K; Jemtland R; Bollerslev J
    Scand J Clin Lab Invest; 2008; 68(8):759-66. PubMed ID: 18618370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
    Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G
    Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hair loss with levetiracetam in five patients with epilepsy.
    Zou X; Hong Z; Zhou D
    Seizure; 2014 Feb; 23(2):158-60. PubMed ID: 24315496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of levetiracetam monotherapy on subjective sleep quality and objective sleep parameters in patients with epilepsy: compared with the effect of carbamazepine-CR monotherapy.
    Cho YW; Kim DH; Motamedi GK
    Seizure; 2011 May; 20(4):336-9. PubMed ID: 21316267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of levetiracetam, carbamazepine, and sodium valproate on P100 and P300 in epileptic patients.
    Tumay Y; Altun Y; Ekmekci K; Ozkul Y
    Clin Neuropharmacol; 2013; 36(2):55-8. PubMed ID: 23503548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary efficacy of levetiracetam in monotherapy.
    Ben-Menachem E
    Epileptic Disord; 2003 May; 5 Suppl 1():S51-5. PubMed ID: 12915342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
    Mintzer S; Boppana P; Toguri J; DeSantis A
    Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monotherapy with Levetiracetam Versus Older AEDs: A Randomized Comparative Trial of Effects on Bone Health.
    Hakami T; O'Brien TJ; Petty SJ; Sakellarides M; Christie J; Kantor S; Todaro M; Gorelik A; Seibel MJ; Yerra R; Wark JD
    Calcif Tissue Int; 2016 Jun; 98(6):556-65. PubMed ID: 26842957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levetiracetam for people with mental retardation and refractory epilepsy.
    Kelly K; Stephen LJ; Brodie MJ
    Epilepsy Behav; 2004 Dec; 5(6):878-83. PubMed ID: 15582836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life, anxiety and depression in adult patients after add-on of levetiracetam and conversion to levetiracetam monotherapy.
    Hagemann A; May TW; Nieder E; Witte-Bölt K; Pohlmann-Eden B; Elger CE; Tergau F; Schulze-Bonhage A; Straub HB; Arnold S; Brandt C
    Epilepsy Res; 2013 Mar; 104(1-2):140-50. PubMed ID: 22959715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery.
    Milligan TA; Hurwitz S; Bromfield EB
    Neurology; 2008 Aug; 71(9):665-9. PubMed ID: 18725591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.